Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice

por Agca, Rabia, Smulders, Yvo, Nurmohamed, Michael
Publicado 2022

Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patients

por Blanken, Annelies B., Raadsen, Reinder, Agca, Rabia, van Sijl, Alper M., Smulders, Yvo M., Nurmohamed, Michael T.
Publicado 2022

The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study

por Baniaamam, Milad, Handoko, M. Louis, Agca, Rabia, Heslinga, Sjoerd C., Konings, Thelma C., van Halm, Vokko P., Nurmohamed, Mike T.
Publicado 2020

Arterial wall inflammation is increased in rheumatoid arthritis compared with osteoarthritis, as a marker of early atherosclerosis

por Agca, Rabia, Blanken, Annelies B, van Sijl, Alper M, Smulders, Yvo M, Voskuyl, Alexandre E, van der Laken, Conny, Boellaard, Ronald, Nurmohamed, Michael T
Publicado 2021

IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis

por Damen, Michelle S. M. A., Agca, Rabia, Holewijn, Suzanne, de Graaf, Jacqueline, Dos Santos, Jéssica C., van Riel, Piet L., Fransen, Jaap, Coenen, Marieke J. H., Nurmohamed, Mike T., Netea, Mihai G., Dinarello, Charles A., Joosten, Leo A. B., Heinhuis, Bas, Popa, Calin D.
Publicado 2017